Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

440 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Acute disseminated encephalomyelitis (ADEM).
Wender M. Wender M. J Neuroimmunol. 2011 Feb;231(1-2):92-9. doi: 10.1016/j.jneuroim.2010.09.019. Epub 2011 Jan 14. J Neuroimmunol. 2011. PMID: 21237518 Review.
[Heterogeneity of demyelination in multiple sclerosis and clinical differences].
Wender M. Wender M. Neurol Neurochir Pol. 2004 Mar-Apr;38(2):123-5. Neurol Neurochir Pol. 2004. PMID: 15307605 Review. Polish.
Association of influenza incidence with multiple sclerosis onset.
Kaźmierski R, Wender M, Guzik P, Zielonka D. Kaźmierski R, et al. Among authors: wender m. Folia Neuropathol. 2004;42(1):19-23. Folia Neuropathol. 2004. PMID: 15119741
Interleukin 12 and interleukin 10 are affected differentially by treatment of multiple sclerosis with glatiramer acetate (Copaxone).
Losy J, Michałowska-Wender G, Wender M. Losy J, et al. Among authors: wender m. Folia Neuropathol. 2002;40(4):173-5. Folia Neuropathol. 2002. PMID: 12572773
Value of Pelli-Robson contrast sensitivity chart for evaluation of visual system in multiple sclerosis patients.
Wender M. Wender M. Neurol Neurochir Pol. 2007 Mar-Apr;41(2):141-3. Neurol Neurochir Pol. 2007. PMID: 17530576 Clinical Trial.
Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers.
Michałowska-Wender G, Losy J, Wender M, Januszkiewicz-Lewandowska D, Nowak J. Michałowska-Wender G, et al. Among authors: wender m. Pol J Pharmacol. 2003 Sep-Oct;55(5):877-80. Pol J Pharmacol. 2003. PMID: 14704481 Clinical Trial.
Effect of methylprednisolone treatment on expression of sPECAM-1 and CXCL10 chemokine in serum of MS patients.
Michałowska-Wender G, Losy J, Szczuciński A, Biernacka-Łukanty J, Wender M. Michałowska-Wender G, et al. Among authors: wender m. Pharmacol Rep. 2006 Nov-Dec;58(6):920-3. Pharmacol Rep. 2006. PMID: 17220550
CCL2 (MCP-1) and CCL5 (RANTES) levels in the peripheral blood of multiple sclerosis patients treated with Glatiramer Acetate (Copaxone).
Losy J, Michałowska-Wender G, Kurdyńska A, Wender M. Losy J, et al. Among authors: wender m. Folia Neuropathol. 2005;43(3):153-5. Folia Neuropathol. 2005. PMID: 16245210
Interleukin 17 receptor in multiple sclerosis patients treated with interferon β-1a.
Michałowska-Wender G, Biernacka-Łukanty J, Lasik Z, Jernas L, Wender M. Michałowska-Wender G, et al. Among authors: wender m. Folia Neuropathol. 2011;49(2):138-41. Folia Neuropathol. 2011. PMID: 21845543
Clinical trials in relapsing-remitting multiple sclerosis /a new proposal for dealing with basic problems and restrictions.
Wender M, Michalowska-Wender G. Wender M, et al. Rev Recent Clin Trials. 2011 Sep;6(3):256-8. doi: 10.2174/157488711796575586. Rev Recent Clin Trials. 2011. PMID: 21682674
440 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback